Overall, our study is the first pan-cancer analysis of C1QTNF6. Compared with other studies, our study provided a landscape of the prognosis and immunity correlation of C1QTNF6 in a variety of cancers, which is conducive to the precise treatment of cancer. The gene discussed is C1QTNF6; the disease is cancer.